Industry news round-up: updates from May 2023
In this latest instalment of our regular monthly column, we summarize a selection of key industry developments that have taken place over the past month, including ISPOR 2023.
From Industry
CorEvitas announces SPHERES Neuromyelitis Optica Spectrum Disorder Registry launches precision medicine program
CorEvitas and The Guthy-Jackson Charitable Foundation announce the SPHERES Neuromyelitis Optica Spectrum Disorder Registry is now complementing its real-world data with clinically annotated biospecimens, creating a unique resource to advance research and treatment for those living with the disease.
Flatiron Health announces expansion into oncology real-world evidence generation
Flatiron Health announced it is expanding its capabilities to generate real-world evidence to provide its customers with a more comprehensive set of data and analytics solutions to help them improve the lives of cancer patients.
Aetion unveils new descriptive analytics application Aetion® Discover to advance rapid, reliable real-world data insights
Aetion unveils new descriptive analytics application Aetion® Discover, a new intuitive interface for exploratory analysis of real-world data to generate swift hypotheses and insights across the biopharmaceutical and medtech lifecycle.
Flatiron Health announces collaboration with Sanofi to streamline clinical trials with automated real-world data capture
Flatiron Health and Sanofi to collaborate across multiple oncology studies, deploying Flatiron Clinical Pipe to automate real-world data capture to streamline clinical trials for patients, sites and sponsors.
PathAI and ConcertAI partner to advance real-world evidence by uniquely linking pathology and real-world clinical datasets
The strategic partnership between PathAI and ConcertAI creates first-in-class quantitative histopathology and curated clinical real-world data solution to enable novel insights for researchers.
Prothena and Walgreens partner to recruit real-world patient population for ASCENT-2 clinical trial in Alzheimer’s disease
Prothena announces collaboration with Walgreens to drive patient awareness, participation and real-world diversity representation in the ASCENT-2 clinical trial of Alzheimer’s drug candidate PRX012.
From the Regulators
FDA takes measures to advance decentralized clinical trials with new draft guidance
The FDA has released a new draft guidance offering advice to sponsors and researchers who wish to employ decentralized clinical trials for gathering evidence on the safety and efficacy of drugs, biologics and devices.
CADTH joint final guidance on reporting real-world evidence studies in Canada
CADTH, in association with Health Canada and INESSS, has produced the final guidance for regulatory and health technology assessment agencies in Canada to advance the integration of real-world evidence in healthcare decision making.
ISPOR 2023 highlights
May saw the ISPOR 2023 annual meeting, the premier conference for anyone involved with health economics and outcomes research, as well as real-world evidence and market access. As a media partner for the event, The Evidence Base team was on site in Boston, MA, USA, to provide coverage of the plenary sessions as well as daily roundups.
Day 1
- ISPOR 2023 – inside the first plenary: affordability, value and the role of the HEOR community
- ISPOR 2023 daily round-ups: Day 1
Day 2
- ISPOR 2023 – inside the second plenary: large language models, artificial intelligence and the role of the HEOR community in these new areas of innovation
- ISPOR 2023 daily round-ups: Day 2
Day 3
- ISPOR 2023 – inside the final plenary: electronic health records and causal inference
- ISPOR 2023 daily round-ups: Day 3
